1.The investigation on clinical features of acute pancreatitis
Ying SHENG ; Qinghua LIU ; Shuming PAN
Chinese Journal of Postgraduates of Medicine 2013;36(17):28-30
Objective To explore the causes and clinical features change of acute pancreatitis,to get early diagnosis of severe acute pancreatitis.Methods The clinical data of 1195 cases of patients with acute pancreatitis were retrospectively analyzed.Results Main causes of acute pancreatitis were still biliary disease 31.72% (379/1195),engorgement 25.44% (304/1195) and hyperlipidemia 16.82% (201/1195).But the causes of severe acute pancreatitis had changed.Hyperlipidemia was 44.59% (140/314),biliary disease accounted for 28.34% (89/314),engorgement accounted for 17.52% (55/314).The incidence of hyperlipidemia severe acute pancreatitis was 69.65% (140/201),the incidence of biliary severe acute pancreatitis was 69.88% (58/83).The incidence of severe acute pancreatitis on patients with body mass index (BMI) ≤25 kg/m2,BMI26-30 kg/m2,BMI≥31 kg/m2 were 5.41% (17/314),24.84% (78/314),69.75% (219/314).There was significant difference (P < 0.05).The incidence of severe acute pancreatitis on patients at age ≤54 years-old,55-69 years-old,≥70 years-old were 12.42% (39/314),21.66%(68/314),65.92% (207/314).There was significant difference (P < 0.05).Conclusions In shanghai,the main causes of acute pancreatitis still is biliary disease and engorgement in the lastest ten years.The causes of severe acute pancreatitis have changed.Hyperlipidemia is main casuse; the second one is biliary disease.The incidence rate of severe acute pancreatitis as well as high BMI and elder age were very high and serious.Thus control of blood-lipid and weight should be strengthened.
2.Expression of Preferentially Expressed Antigen of Melanoma Gene in Children with Acute Leukemia and Its Clinical Applications Compared with WT1 Gene
ying, NIE ; kai-li, PAN ; an-sheng, LIU
Journal of Applied Clinical Pediatrics 2006;0(15):-
0.05).Thirty-four cases of newly diagnosed children with CR rate was 88.2% (30 cases).Which the expression of PRAME gene,WT1 gene were both positive and negative groups of children with CR rates were 62.5% and 100.0%,there was no significant difference between the 2 groups(P
3.Application of tailored radiofrequency (TRF) in T2-FLAIR MR imaging
Jianrong DING ; Jingli PAN ; Sheng XU
Chinese Medical Equipment Journal 2003;0(12):-
Objective To investigate the influence of TRF on high-intensity cerebrospinal fluid artifacts in T2-FLAIR MR imaging.Methods In a GE Signa Twinspeed 1.5T system,50 cases were examined with T2-FLAIR sequences including 2 different optional imaging parameters according to the augmentation of TRF.Results TRF pulses significantly improved image quality(P
4.Effects of Passaging on the Proliferation,Differentiation and Apoptosis of Neural Stem Cells from Rat Embryonic Brains.
Shengxuan ZHOU ; Jinqian PAN ; Sheng YE
Journal of Medical Research 2006;0(01):-
Objective To investigate the effects of passaging on the proliferation,differentiation and apoptosis of neural stem cells.Methods Neural stem cells both from prime culture(P0) and twice-passaged culture(P2) were tested by enzyme immunoassay for proliferation and fluorescent activated cell sorting for apoptosis by Annexin V-FITC and propidium iodide.After being enduced to differentiation for 7 days,they were detected by the neuronal marker MAP2 and the astrocyte marker GFAP with nuclei staining by Hoechst 33342 additionally.The ratios of MAP2+/Hoechst+ and GFAP+/Hoechst+ were calculated.Results The absorbance of NSCs from P0 and P2 is 1.1899?0.0485(n=13)and 0.3526?0.1053(n=11)(P=0.000).Analyses of apoptosis using cytoflurometry are 40.91%?12.74% for P0(n=8)and 24.31%?13.01% for P2(n=9,P=0.018).The ratios of MAP2+/Hoechst+ and GFAP+/Hoechst+ of NSCs from P0 were 58.81%?9.69%(n=10)和22.85%?4.36%(n=10) while the ones for P2 were 27.84%?5.70%(n=10)and 49.32%?6.95%(n=10,P=0.000).Conclusions By passaging the proliferation and apoptosis of NSCs decreases and they differentiate into less neurons and more astrocytes.
5.Small non-coding RNA and RNA activation.
Chinese Journal of Pathology 2013;42(4):280-282
Animals
;
Apoptosis
;
Cadherins
;
genetics
;
metabolism
;
Epigenesis, Genetic
;
Gene Expression Regulation, Neoplastic
;
Humans
;
MicroRNAs
;
genetics
;
metabolism
;
physiology
;
Neoplasm Invasiveness
;
Neoplasms
;
genetics
;
metabolism
;
pathology
;
therapy
;
RNA, Double-Stranded
;
genetics
;
metabolism
;
physiology
;
RNA, Small Interfering
;
genetics
;
metabolism
;
physiology
;
RNA, Small Untranslated
;
genetics
;
metabolism
;
physiology
;
therapeutic use
;
Transcriptional Activation
6.Therapeutic effect of locking proximal humerus plate in treatment of the elderly patients with complex humeral proximal fractures
Mingfeng XUE ; Jiaping DAI ; Chunmin TONG ; Jieen PAN ; Jianming SHENG
Chinese Journal of Geriatrics 2012;31(1):48-50
ObjectiveTo observe the clinical effects of locking proximal humerus plate(LPHP) in the treatment of complex proximal humeral fracture of aged patients and to analyze the influencing factors. Methods Among 39 cases with complex humeral fractures (aged 60-83 years),there were 29 cases with three-part fractures and 10 with four-part fractures according to the Neer classification.They were operated by LPHP via deltoid-pectoral approach. Neer numerical rating system was employed to evaluate postoperative function of shoulders.Results39 cases were followed up for average of 16 months.According to Neer numerical rating system,the excellence rates of three-part fractures and four-part fractures were 86.2% (25 cases) and 50.0% (5 cases),respectively,with total excellence rate of 76.9%(30 cases). Age (OR =1.314, P<0.05) and fracture type ( OR =1.295, P<0.05)ofpatientswereindependentriskfactorsforprognosis of proximal humeral fracture of aged patients by multiple logistic regression. Conclusions LPHP is an effective implant for treating complex proximal humeral fracture of aged patients,with age and fracture types as important risk factors of prognosis.<英文关键词>=humeral fractures
8.Association between polymorphisms of CYP3A5,MDR1,COX-2 and chemotherapy outcomes of advanced NSCLC
Jihong PAN ; Jinxiang HAN ; Jianmei WU ; Lijun SHENG ; Hainan HUANG
Journal of International Oncology 2008;35(5):395-399
Objective To investigate whether genotypes of CYP3A5,MDR1 and cyclooxygenase-2 are associated with the sensitivity of vinorelbine-platinum to NSCLC.Methods The genotypes of CYP3A5(*3),MDR1 (2677G>T at exon 21 and 3435C>T at exon 26 and their haplotypes),cyclooxygenase-2 (-1 195G>A) were determined by RFLP-PCR and chemotherapy responses were analyzed in 69 non-small-celllung cancer (NSCLC) Chinese Han patients.They received a combination chemotherapy of vinorelbine-cispla-tin.Chi-square test was used to investigate the potential association of genotype with chemotherapy response.OR and 95% C1 were calculated.Results The 3435 CC genotype was associated with a significantly betterchemotherapy response compared with the combined 3435 CT and 1Tr genotypes(P=0.033).The 2677 GG genotype was also associated with a significantly better chemotherapy response compared with the combined 2677 GT and IT genotype(P=0.012).Moreover.patients with the 2677 G-3435 C haplotype seemed to have a better response to chemotherapy compared with those with the other haplotypes(P=0.063).CYP3A5*3 was not likely to correlate with sensitivity of vinorelbine-platinum to NSCLC.Cyclooxygenase-2-1195G>A was likely to have better response to vinorelbine but not statistically significant(P=0.067).Conclusion Polymor-Dhisms of MDR1 3435 C>T and MDR1 2677 G>A/T can be used for predicting treatment response to vinorel-bine-cisplatin chemotherapy in NSCLC patients.
10.Protein disulfide isomerase’s role in cardiovascular disease
Mengting SHENG ; Zirui HANG ; Liming PAN ; Junming LI
Tianjin Medical Journal 2015;(10):1205-1208
Protein disulfide isomerase (PDI) is one of thiol-disulfide oxidoreductases that mainly located in the endo?plasmic reticulum (ER). It is generally known that PDI caralyzes the formation,rearrangement,breakage of disulfide bonds, and this enzyme is effective in regulation of protein folding. Now it is also known as a biomarker of cardiovascular disease. Protein disulfide isomerase can reduce infarct size and myocardial apoptosis in acute myocardial infarction (AMI). PDI can also improve changes of cardiac vulnerability in diabetic cardiomyopathy (DCM). Further more, it is also shown that PDI play an important role in hypertension and thrombosis. Therefore, this paper review the effects of protein disulfide isomerase in cardiovascular diseases.